Todos Medical, Ltd. (OTCQB: TOMDF), a comprehensive medical diagnostics and related solutions company, today announced that its majority-owned subsidiary 3CL Pharma, Ltd. received LGC Group’s Informed Sport Certification for Tollovid®, the Company’s proprietary 3CL protease inhibitor dietary supplement product currently for sale on Amazon, MyTollovid.com and at The Alchemist’s Kitchen in New York City.
“We have heard from many elite athletes looking for additional immune support that they would love to try our 3CL protease inhibitor supplement Tollovid but are not willing to take the risk without an external certification ensuring they are not consuming a banned performance enhancing substance,” said Gerald Commissiong, President & CEO of Todos Medical and former collegiate & professional American football player. “I certainly understand the importance of ensuring only the highest quality, safe products are used in athletic competition, and for this reason we went through the rigorous process of getting both our cGMP manufacturer and our Tollovid product Informed Sports certified. With this accreditation, athletes can buy and use Tollovid with confidence to help them stay on the playing field and maximize their training opportunities. As we saw from the feedback surrounding the Celebrity Sweat Superbowl Event, athletes are a key demographic for Tollovid given their potential exposure, and so with this new certification we believe we will be able to target a new, important market. We have had a lot of positive feedback from athletes looking for solutions over the past couple months and look forward to rolling out some new initiatives.”
Informed Sport is a global testing and certification program for sports and nutritional supplements. Supplement products are tested by LGC Group’s world-class anti-doping laboratory for contamination against a broad range of banned substances in sport, using ISO 17025 accredited methods. When you see the Informed Sport quality mark on a product, you can be assured that it has passed the most stringent sports supplements testing. Established in 2008, Informed Sport has certified over 3,000 unique products sold in over 127 countries globally. Its laboratories in the U.S. and the U.K. test over 20,000 samples per year. Elite athletes can trust their reputation and careers with Informed Sport certified products.
Tollovid is a dietary supplement product made from natural ingredients that help support and maintain healthy immune function and also has potent 3CL protease inhibition properties based upon in vitro functional assays that show strong inhibition of 3CL protease activity. Tollovid’s 3CL protease IC50 binding affinity is at least ten times as strong as Ivermectin’s published 3CL protease IC50 binding affinity. Tollovid binds to the active site (receptor binding domain) of the 3CL protease. Tollovid has a 5-day dosing regimen, with 4 doses of 3 pills taken each day that provides maximum immune support.
Tollovir® is a 3CL protease inhibitor and anti-cytokine therapeutic candidate for the treatment of the nidovirus subcategory of coronaviruses that includes SARS-CoV-2, COVID-19, SARS-CoV-1, MERS and 229E. Tollovir is made from all natural ingredients that are qualified to ensure strong inhibition of the 3CL protease in vitro, as well as strong anti-cytokine activity. Tollovir is currently in a Phase 2 clinical trial in Israel for the treatment of patients hospitalized with COVID-19. Tollovir will be developed for the treatment of hospitalized COVID-19 (severe and critical), moderate COVID-19, long-haul COVID and potentially pediatric COVID-19. Todos has licensed rights for Tollovir to T-Cell Protect Hellas S.A. for the Greek market.
About Todos Medical Ltd.
Founded in Rehovot, Israel with offices in New York City, Todos Medical Ltd. (OTCQB: TOMDF) engineers’ life-saving diagnostic solutions for the early detection of a variety of cancers. The Company’s state-of-the-art and patented Todos Biochemical Infrared Analyses (TBIA) is a proprietary cancer-screening technology using peripheral blood analysis that deploys deep examination into cancer’s influence on the immune system, looking for biochemical changes in blood mononuclear cells and plasma. Todos’ two internally developed cancer-screening tests, TMB-1 and TMB-2 have received a CE mark in Europe. Todos recently acquired U.S.-based medical diagnostics company Provista Diagnostics, Inc. to gain rights to its Alpharetta, Georgia-based CLIA/CAP certified lab currently performing PCR COVID testing and Provista’s proprietary commercial-stage Videssa® breast cancer blood test.
Todos is also developing blood tests for the early detection of neurodegenerative disorders, such as Alzheimer’s disease. The Lymphocyte Proliferation Test (LymPro Test™) is a diagnostic blood test that determines the ability of peripheral blood lymphocytes (PBLs) and monocytes to withstand an exogenous mitogenic stimulation that induces them to enter the cell cycle. It is believed that certain diseases, most notably Alzheimer’s disease, are the result of compromised cellular machinery that leads to aberrant cell cycle re-entry by neurons, which then leads to apoptosis. LymPro is unique in the use of peripheral blood lymphocytes as a surrogate for neuronal cell function, suggesting a common relationship between PBLs and neurons in the brain.
Todos has entered into distribution agreements with companies to distribute certain novel coronavirus (COVID-19) test kits. The agreements cover multiple international suppliers of PCR testing kits and related materials and supplies, as well as antibody testing kits from multiple manufacturers after completing validation of said testing kits and supplies in its partner CLIA/CAP certified laboratory in the United States. Additionally, Todos has entered into a joint venture with NLC Pharma to pursue the development of diagnostic tests targeting the 3CL protease, as well as 3CL protease inhibitors that target a fundamental reproductive mechanism of coronaviruses.